Target intelligence / Profile preview

RNA polymerase I and III subunit D (POLR1D)

Target
POLR1D
Molecular classification
Enzyme, Transcription factor
01

Overview

RNA polymerase I and III subunit D (POLR1D) is a protein-coding gene encoding a key common subunit of RNA polymerase I and RNA polymerase III complexes[3]. Both complexes catalyze the DNA-dependent synthesis of ribosomal RNA (rRNA) and, for polymerase III, additional small non-coding RNAs including tRNA, snRNAs, and miRNAs[3][5]. POLR1D is essential for ribosome biogenesis and is highly expressed in embryonic tissues that will form the craniofacial skeleton[1][4]. Mutations in POLR1D disrupt rRNA production, leading to pathologies such as Treacher Collins syndrome, a rare congenital disorder characterized by craniofacial anomalies. The disease mechanism involves increased apoptosis of neural crest cells due to reduced ribosome biogenesis, with genetic evidence showing that cell death is p53-dependent in model organisms[4]. The protein is a component of the multi-subunit RNA polymerase I (13+ subunits) and polymerase III (17+ subunits) complexes[7]. There are multiple transcript variants due to alternative splicing[3]. POLR1D deficiency does not currently have drugs targeting it directly nor established mechanisms for pharmacological modulation.

Other names
RNA polymerase I subunit DDNA-directed RNA polymerase I subunit DRNA polymerase I 16 kDa subunitRPAC2RPA16AC19RPO1-3RPA9RPC16Polymerase (RNA) I polypeptide D, 16kDaRNA polymerases I and III subunit AC2
02

Biological functions

Ribosomal RNA (rRNA) synthesisTransfer RNA (tRNA) synthesisRibosome biogenesisEmbryonic craniofacial and cartilage developmentCell proliferation
03

Disease associations

Treacher Collins syndrome (craniofacial developmental disorder)Coloboma (possible association)Other ribosomopathies
04

Safety considerations

Loss of function can cause Treacher Collins syndrome, resulting in craniofacial defects[2][5].Associated with tissue-specific apoptosis during development[2][4].
05

Biomarkers

Mutations in POLR1D serve as genetic biomarkers for Treacher Collins syndrome[2][5].

Beyond the preview

Go deeper on RNA polymerase I and III subunit D (POLR1D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA polymerase I and III subunit D (POLR1D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call